Have a personal or library account? Click to login
Efficacy, effectiveness and safety of Comirnaty vaccine in the prevention of symptomatic and asymptomatic SARS-CoV-2 infections Cover

Efficacy, effectiveness and safety of Comirnaty vaccine in the prevention of symptomatic and asymptomatic SARS-CoV-2 infections

Pomeranian Journal of Life Sciences
Volume 68 (2022): Issue 2 (June 2022)
By: Mikołaj Chlubek and  Irena Baranowska-Bosiacka  
Open Access
|Sep 2022
DOI: https://doi.org/10.21164/pomjlifesci.830 | Journal eISSN: 2719-6313 | Journal ISSN: 2450-4637
Journal RSS Feed
Language: English
Page range: 25 - 29
Published on: Sep 2, 2022
Published by: Pomeranian Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
SARS-CoV-2,
COVID-19,
Comirnaty,
Pfizer/BioNTech,
mRNA vaccine,
vaccine efficacy,
vaccine effectiveness,
vaccine safety
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Surgery,
Surgery, other,
Public health

© 2022 Mikołaj Chlubek, Irena Baranowska-Bosiacka, published by Pomeranian Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 68 (2022): Issue 2 (June 2022)Next article